|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.99 USD | +1.89% |
|
-3.87% | +216.26% |
| 07-29 | Corcept Therapeutics Incorporated, Q2 2026 Earnings Call, Jul 29, 2026 | |
| 07-29 | (CORT) Corcept Therapeutics Expects Full Year 2026 Revenue Range $1.1B - $1.2B, vs. FactSet Est of $999.5M | MT |
| Market Cap | 11.67B 10.09B 9.43B 8.65B 16.26B 1,111B 16.52B 111B 43.41B 557B 43.82B 42.86B 1,840B | P/E 2026 * |
53.3x | P/E 2027 * | 24.8x |
|---|---|---|---|---|---|
| Enterprise Value | 11.46B 9.91B 9.25B 8.49B 15.97B 1,090B 16.22B 109B 42.61B 546B 43.02B 42.08B 1,807B | EV / Sales 2026 * |
10.3x | EV / Sales 2027 * | 6.87x |
| Free-Float |
66.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corcept Therapeutics Incorporated
| 1 day | +1.89% | ||
| 1 week | -3.87% | ||
| Current month | -3.87% | ||
| 1 month | +17.04% | ||
| 3 months | +115.59% | ||
| 6 months | +166.42% | ||
| Current year | +216.26% |
| 1 week | 107.32 |  | 115 |
| 1 month | 84.88 | | 122.21 |
| Current year | 28.66 | | 122.21 |
| 1 year | 28.66 | | 122.21 |
| 3 years | 20.84 | | 122.21 |
| 5 years | 15.82 | | 122.21 |
| 10 years | 5.24 | | 122.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 1998-12-31 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 2021-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 1998-12-31 |
James Wilson
CHM | Chairman | 82 | 1998-12-31 |
David Mahoney
BRD | Director/Board Member | 71 | 2004-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 | Sell | Chief Technology Officer | -1,540 | 0.0014% | ||
| 8/3/26 | Fiscal year | Executive/Senior Manager | 60,915 | 0.0567% | ||
| 7/30/26 | Fiscal year | Chief Financial Officer | 240,000 | 0.2236% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.89% | -3.87% | +53.97% | +264.08% | 11.67B | |
| -1.11% | +2.60% | +83.92% | +159.57% | 1,062B | |
| -0.32% | +0.04% | +49.51% | +48.16% | 619B | |
| +0.33% | -2.43% | +23.13% | +62.88% | 431B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 358B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 293B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 247B | |
| +0.60% | +5.82% | +43.15% | +61.13% | 219B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 200B | |
| +2.10% | +2.62% | +21.16% | +65.64% | 162B | |
| Average | +1.00% | -2.59% | +36.51% | +70.55% | 360.4B | |
| Weighted average by Cap. | +0.24% | -0.85% | +47.88% | +75.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.11B 960M 897M 823M 1.55B 106B 1.57B 10.52B 4.13B 52.97B 4.17B 4.08B 175B | 1.63B 1.41B 1.32B 1.21B 2.27B 155B 2.31B 15.45B 6.06B 77.75B 6.12B 5.99B 257B |
| Net income | 242M 209M 196M 179M 337M 23.04B 343M 2.29B 900M 11.55B 909M 889M 38.17B | 645M 558M 521M 478M 899M 61.4B 913M 6.11B 2.4B 30.78B 2.42B 2.37B 102B |
| Net Debt | -213M -185M -172M -158M -297M -20.31B -302M -2.02B -794M -10.18B -801M -784M -33.65B | -474M -410M -383M -351M -661M -45.13B -671M -4.49B -1.76B -22.62B -1.78B -1.74B -74.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$110.06 | +1.95% | 299,736 |
| 26-08-06 | US$107.95 | -2.48% | 761,834 |
| 26-08-05 | US$110.69 | +0.81% | 846,859 |
| 26-08-04 | US$109.80 | -2.66% | 1,266,014 |
| 26-08-03 | US$112.80 | -1.48% | 1,688,643 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CORT Stock
Select your edition
All financial news and data tailored to specific country editions
